The impact of routine utilization of two assessment scales on management of antipsychotic-induced side effects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN88391730

Enrollment

Registered

2005-09-30

Start date

2003-10-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders: Psychosis Mental and Behavioural Disorders Psychosis

Interventions

Two assessment scales

Eligibility

Inclusion criteria

Inclusion criteria: 30 (study) and 30 (control) patients in the Forensic Mental Health Unit, Homerton

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Changes/differences in the scales ratings at the baseline and the end-assessment within the control and study group and between groups. Differences in the general mental health rating at the beginning and the end-assessment between the control and the study groups. Associations between side effects assessment and the general mental health status.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026